Bristol-Myers Squibb

Bristol-Myers Squibb promotes the work of its employees
Medical Marketing and Media
Tue, 09/29/15 - 10:08 pm
Bristol-Myers Squibb
Don't be quick to peg Merck's Keytruda in second place for NSCLC, analyst says
Fierce Pharma Marketing
Mon, 09/28/15 - 10:15 am
Merck
Keytruda
non-small cell lung cancer
Bristol-Myers Squibb
Opdivo
Why Opdivo Is Key for Bristol-Myers Squibb
Yahoo/Market Realist
Mon, 09/28/15 - 08:40 am
Opdivo
Bristol-Myers Squibb
Cometriq Plays Wallflower As Opdivo's Dance Card Fills
Seeking Alpha
Mon, 09/28/15 - 08:23 am
Bristol-Myers Squibb
Opdivo
Cometriq
Exelixis
kidney cancer
Bristol's Opdivo boosts kidney cancer survival beyond two years
Yahoo/Reuters
Sat, 09/26/15 - 09:54 am
Bristol-Myers Squibb
Opdivo
kidney cancer
Novartis
Afinitor
How Did Bristol-Myers Squibb’s Virology Segment Perform in 2Q15?
Yahoo/Market Realist
Wed, 09/23/15 - 09:56 pm
Bristol-Myers Squibb
virology
Bristol-Myers Squibb’s Oncology Segment in 2Q15
Yahoo/Market Realist
Wed, 09/23/15 - 09:53 pm
Bristol-Myers Squibb
oncology
Watch out, Afinitor. Bristol's 'breakthrough' Opdivo is coming for you
Fierce Pharma Marketing
Fri, 09/18/15 - 09:14 pm
Bristol-Myers Squibb
Afinitor
Opdivo
Novartis
kidney cancer
Bristol-Myers' Opdivo Gets Breakthrough Status for Kidney Cancer
NASDAQ.com
Wed, 09/16/15 - 09:42 am
Bristol-Myers Squibb
Opdivo
kidney cancer
breakthrough therapies
Biotechs Coming Off One Of The Busiest Weeks In Recent Memory
Yahoo/Benzinga
Tue, 09/15/15 - 09:04 am
biotech
Gilead Sciences
Akebia
Vitae
Clovis Oncology
AstraZeneca
Bristol-Myers Squibb
Flexion
Tetraphase Pharmaceuticals
Incyte Hits High On Cancer Drug Data, Buyout Talk
Investors.com
Fri, 09/11/15 - 05:56 pm
Incyte
M&A
epacadostat
Yervoy
melanoma
Bristol-Myers Squibb
It's Official, Merck Just Caved. Who's Next?
Motley Fool
Tue, 09/8/15 - 02:05 pm
Merck
drug pricing
Keytruda
Opdivo
Bristol-Myers Squibb
Bristol-Myers' latest PD-1 win could pave the path to earlier use
Fierce Biotech
Tue, 09/8/15 - 02:03 pm
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
New data expected at lung-cancer conference on experimental drug combos
Medical Marketing and Media
Fri, 09/4/15 - 09:01 am
lung cancer
Opdivo
Yervoy
Bristol-Myers Squibb
tremelimumab
MEDI4736
AstraZeneca
Roche
atezolizumab
Bristol-Myers' Opdivo snags FDA priority review for bigger lung cancer use
Fierce Pharma Marketing
Wed, 09/2/15 - 10:16 am
Opdivo
Bristol-Myers Squibb
FDA
priority review
non-small cell lung cancer
Will Bristol-Myers (BMY) Stock Be Helped by Myeloma Gaining FDA Priority Review Approval?
TheStreet.com
Tue, 09/1/15 - 06:46 pm
Bristol-Myers Squibb
priority review
FDA
Multiple Myeloma
Empliciti
Bristol-Myers and AbbVie speed toward FDA approval with a 'breakthrough' cancer drug
Fierce Biotech
Tue, 09/1/15 - 06:38 pm
AbbVie
Bristol-Myers Squibb
FDA
elotuzumab
Multiple Myeloma
J&J-Bayer and Pfizer-BMS look for marketing advantages in real-world Xarelto, Eliquis data
Fierce Pharma
Tue, 09/1/15 - 06:37 pm
JNJ
Bayer
Pfizer
Bristol-Myers Squibb
Eliquis
bloodthinners
Xarelto
Bristol-Myers buys rights to fibrosis drug with option to buy developer Promedior
Yahoo/AP
Mon, 08/31/15 - 09:53 am
Bristol-Myers Squibb
PRM-151
idiopathic pulmonary fibrosis
Promedior
Patient education 'useless' when it comes to Eliquis adherence: study
Fierce Pharma
Mon, 08/31/15 - 08:25 am
patient education
Eliquis
Bristol-Myers Squibb

Pages